re: Ann: PolyNovo Partners in the Field of Ae...
Agree that more exposure might be helpful. Once the spp is out of the way and another development has been signed up further validating the technology "the market" will take notice. In the meantime a buying opportunity exists.
ISN sp has nearly doubled since their recent placement and quite a bit of that must have been down to promotion. CZDs modest CR to SIs` and shareholders will be done in a week or so and I see no reason CZD won`t also perform, even more so if it coincides with a BARDA contract or another development application as alluded to in the recent update. Polynovo has it`s safety and efficacy in humans behind it and the news flow should get better from here as per the announcement a couple of days ago.
cheers
CZD Price at posting:
7.6¢ Sentiment: Buy Disclosure: Held